Articles

Medicine is an essential service. Yet, healthcare providers still need to make enough profit to cover their overhead costs if they want to keep their doors open. That is why it is essential for your business and community that claims are processed accurately and that you get reimbursed for your services.

Chicago, IL—It is well documented that clinical trials thus far have for the most part excluded underserved populations, and that means the results of these trials cannot be generalized to society at large. Fortunately, the federal government and medical societies have taken aim at remedying this imbalance in accrual for clinical trials.

Have you ever asked ChatGPT to create a bio on yourself? Was it spot-on? Somewhat accurate? Total fiction? ChatGPT and similar programs, such as Google’s Med-PaLM 2 and Bard, and Microsoft’s Bing Chat, are generative artificial intelligence (AI) programs that use large language models to respond to prompts.

Chicago, IL—The presidential theme for the 2023 American Society of Clinical Oncology Annual Meeting was “Partnering With Patients: The Cornerstone of Clinical Care and Research.”

Chicago, IL—The addition of the CDK4/6 inhibitor ribociclib (Kisqali) to endocrine therapy significantly improved invasive disease-free survival in patients with hormone receptor (HR)-positive, HER2-negative, early breast cancer, according to interim results from the phase 3 NATALEE trial, which were presented at the 2023 American Society of Clinical Oncology Annual Meeting.

Chicago, IL—The addition of the PD-1 inhibitor pembrolizumab (Keytruda) to chemotherapy with or without bevacizumab (Avastin) resulted in a substantial and clinically meaningful improvement in overall survival (OS) in patients with persistent, recurrent, or metastatic cervical cancer, according to the final OS analysis of the phase 3 KEYNOTE-826 trial.

Chicago, IL—Interim results from the phase 3 COMMANDS trial demonstrated that first-line treatment with luspatercept-aamt (Reblozyl) increased hemoglobin levels and enabled nearly twice as many patients with transfusion-dependent, lower-risk myelodysplastic syndromes (MDS) to avoid red blood cell transfusions during the first 24 weeks of the study compared with standard-of-care epoetin alfa.

Cancer researchers continue to make progress in developing tests using liquid biopsies that could complement and even serve as an alternative to traditional tissue biopsies.

Artificial intelligence (AI)-powered medical treatment options are on the rise and have the potential to improve diagnostic accuracy, but a new study led by University of Arizona Health Sciences researchers found that approximately 52% of participants would choose a human doctor rather than AI for diagnosis and treatment.